These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36773046)

  • 41. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
    van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
    BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
    Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
    Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson's disease on MRI.
    Müller SJ; Khadhraoui E; Hansen N; Jamous A; Langer P; Wiltfang J; Riedel CH; Bouter C; van Riesen C; Maass F; Bartl M; Lange C; Ernst M
    BMC Neurol; 2023 Mar; 23(1):114. PubMed ID: 36944914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
    Hansson O; Janelidze S; Hall S; Magdalinou N; Lees AJ; Andreasson U; Norgren N; Linder J; Forsgren L; Constantinescu R; Zetterberg H; Blennow K;
    Neurology; 2017 Mar; 88(10):930-937. PubMed ID: 28179466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
    Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
    Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
    Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
    Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.
    Archer DB; Mitchell T; Burciu RG; Yang J; Nigro S; Quattrone A; Quattrone A; Jeromin A; McFarland NR; Okun MS; Vaillancourt DE
    Mov Disord; 2020 Aug; 35(8):1388-1395. PubMed ID: 32357259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of mean diffusivity, R2* relaxation rate and morphometric biomarkers for the clinical differentiation of parkinsonism.
    Chougar L; Lejeune FX; Faouzi J; Morino B; Faucher A; Hoyek N; Grabli D; Cormier F; Vidailhet M; Corvol JC; Colliot O; Degos B; Lehéricy S
    Parkinsonism Relat Disord; 2023 Mar; 108():105287. PubMed ID: 36706616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.
    Pirker W; Asenbaum S; Bencsits G; Prayer D; Gerschlager W; Deecke L; Brücke T
    Mov Disord; 2000 Nov; 15(6):1158-67. PubMed ID: 11104200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toward More Accessible Fully Automated 3D Volumetric MRI Decision Trees for the Differential Diagnosis of Multiple System Atrophy, Related Disorders, and Age-Matched Healthy Subjects.
    Kim J; Young GS; Willett AS; Pitaro AT; Crotty GF; Mesidor M; Jones KA; Bay C; Zhang M; Feany MB; Xu X; Qin L; Khurana V
    Cerebellum; 2023 Dec; 22(6):1098-1108. PubMed ID: 36156185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Hussl A; Mahlknecht P; Scherfler C; Esterhammer R; Schocke M; Poewe W; Seppi K
    Mov Disord; 2010 Oct; 25(14):2444-9. PubMed ID: 20878992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deep learning to differentiate parkinsonian disorders separately using single midsagittal MR imaging: a proof of concept study.
    Kiryu S; Yasaka K; Akai H; Nakata Y; Sugomori Y; Hara S; Seo M; Abe O; Ohtomo K
    Eur Radiol; 2019 Dec; 29(12):6891-6899. PubMed ID: 31264017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes.
    Holmberg B; Johnels B; Ingvarsson P; Eriksson B; Rosengren L
    Parkinsonism Relat Disord; 2001 Sep; 8(1):23-31. PubMed ID: 11472877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders.
    Nilsson J; Constantinescu J; Nellgård B; Jakobsson P; Brum WS; Gobom J; Forsgren L; Dalla K; Constantinescu R; Zetterberg H; Hansson O; Blennow K; Bäckström D; Brinkmalm A
    Mov Disord; 2023 Feb; 38(2):267-277. PubMed ID: 36504237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes.
    Quadalti C; Calandra-Buonaura G; Baiardi S; Mastrangelo A; Rossi M; Zenesini C; Giannini G; Candelise N; Sambati L; Polischi B; Plazzi G; Capellari S; Cortelli P; Parchi P
    NPJ Parkinsons Dis; 2021 Oct; 7(1):93. PubMed ID: 34635674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism.
    Mueller C; Hussl A; Krismer F; Heim B; Mahlknecht P; Nocker M; Scherfler C; Mair K; Esterhammer R; Schocke M; Wenning GK; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2018 Sep; 54():90-94. PubMed ID: 29643007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic Approach to Atypical Parkinsonian Syndromes.
    McFarland NR
    Continuum (Minneap Minn); 2016 Aug; 22(4 Movement Disorders):1117-42. PubMed ID: 27495201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
    Berganzo K; Tijero B; Somme JH; Llorens V; Sánchez-Manso JC; Low D; Iodice V; Vichayanrat E; Mathias CJ; Lezcano E; Zarranz JJ; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2012 Jan; 18(1):45-8. PubMed ID: 21908227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.